AXSM
Axsome Therapeutics Inc

11,738
Loading...
Loading...
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
683

Frequently Asked Questions

What is Market Cap of Axsome Therapeutics Inc?
What is the 52-week high for Axsome Therapeutics Inc?
What is the 52-week low for Axsome Therapeutics Inc?
What is Axsome Therapeutics Inc stock price today?
What was Axsome Therapeutics Inc stock price yesterday?
What is the PE ratio of Axsome Therapeutics Inc?
What is the Price-to-Book ratio of Axsome Therapeutics Inc?
What is the 50-day moving average of Axsome Therapeutics Inc?
How many employess does Axsome Therapeutics Inc has?

Latest AXSM News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.